Palantir's Record Q3 Fails to Sustain Stock Rally as Valuation and Expectations Weigh

What happened

Palantir reported record third-quarter revenue of $2.313 billion, up 96% year over year, with net income surpassing $1 billion and billings reaching $2.454 billion, driven by extraordinary demand for its AIP across government and commercial sectors. Despite these monster results, the stock fell sharply, with shares closing at $175.40 on November 3, down more than 9% from the recent high, reflecting that even triple-digit growth could not exceed already sky-high investor expectations. The master report highlights that at current levels, PLTR trades at about 52.9x guided 2026 revenue and 114.6x trailing earnings, leaving no margin of safety. Key concerns include the lack of disclosed sovereign AI backlog, non-U.S. revenue remaining at only 19% of total, and a narrowing of commercial customer additions. Consequently, the market is now demanding not just exceptional execution but continued upside surprises, which the company may struggle to deliver in the near term.

Implication

Investors should treat this quarter as confirmation that Palantir's core business remains exceptionally strong, but also that the stock is priced for perfection. The sharp decline after excellent numbers signals a shift in market sentiment, where even stellar results are no longer enough to sustain the premium multiple. Short-term, the stock is likely to remain volatile, and current levels near $175 offer no attractive risk-reward compared to the master report's base case of $180 and bear case of $140. The key catalysts to monitor are whether sovereign AI announcements convert into disclosed contract dollars, whether non-U.S. revenue share rises above 19%, and whether U.S. commercial large-deal formation holds at recent levels. Until those evidence points show up, a disciplined approach is to wait for a pullback toward the $145 attractive entry or a de-rating in valuation before adding exposure.

Thesis delta

The thesis remains unchanged: Palantir has a real moat and exceptional operating momentum, but the stock is overvalued relative to its near-term growth visibility. Today's news—a blowout quarter met with a stock decline—reinforces that the market has already priced in continued upside surprises and is now focusing on sovereign AI and international expansion, which remain unproven. Therefore, the WAIT rating stays intact with no adjustment to conviction.